Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
RxSight, Inc. - Common Stock
(NQ:
RXST
)
5.950
-0.050 (-0.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RxSight, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
3 Stocks to Buy BEFORE They Become Household Names
↗
January 12, 2024
The best way to find 100 baggers is to invest in undiscovered stock gems that have yet to become household names.
Via
InvestorPlace
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
Breaking Down RxSight: 5 Analysts Share Their Views
↗
January 08, 2024
Via
Benzinga
Analyst Expectations for RxSight's Future
↗
December 13, 2023
Via
Benzinga
RxSight: Q3 Earnings Insights
↗
November 09, 2023
Via
Benzinga
Where RxSight Stands With Analysts
↗
August 08, 2023
Via
Benzinga
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
January 07, 2024
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Educational and Product Announcements for AAO 2023
November 02, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight's Earnings: A Preview
↗
August 04, 2023
Via
Benzinga
RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
October 26, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
August 23, 2023
From
RxSight, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 08, 2023
Via
Benzinga
RxSight, Inc. Reports Second Quarter 2023 Financial Results
August 07, 2023
From
RxSight, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings for RxSight
↗
July 12, 2023
Via
Benzinga
Analyst Expectations for RxSight's Future
↗
April 13, 2023
Via
Benzinga
Looking Into RxSight's Return On Capital Employed
↗
March 09, 2023
Via
Benzinga
RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023
July 25, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+
↗
July 12, 2023
Needham analyst David Saxon reiterated a Buy rating on RxSight, Inc. (NASDAQ: RXST),
Via
Benzinga
RxSight, Inc. Reports First Quarter 2023 Financial Results
May 09, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the Bank of America Healthcare Conference
April 26, 2023
From
RxSight, Inc.
Via
GlobeNewswire
5 Analysts Have This to Say About RxSight
↗
March 07, 2023
Via
Benzinga
Earnings Preview: RxSight
↗
March 03, 2023
Via
Benzinga
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
April 25, 2023
From
RxSight, Inc.
Via
GlobeNewswire
Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
April 24, 2023
From
RxSight, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
↗
April 13, 2023
Via
Benzinga
RxSight, Inc. to Present at the Needham Healthcare Conference
April 05, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 06, 2023
From
RxSight, Inc.
Via
GlobeNewswire
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
February 28, 2023
From
RxSight, Inc.
Via
GlobeNewswire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today